De Munari et al., 2003 - Google Patents
Structure-based design and synthesis of novel potent Na+, K+-ATPase inhibitors derived from a 5α, 14α-androstane scaffold as positive inotropic compoundsDe Munari et al., 2003
- Document ID
- 2450929825995204628
- Author
- De Munari S
- Cerri A
- Gobbini M
- Almirante N
- Banfi L
- Carzana G
- Ferrari P
- Marazzi G
- Micheletti R
- Schiavone A
- Sputore S
- Torri M
- Zappavigna M
- Melloni P
- Publication year
- Publication venue
- Journal of medicinal chemistry
External Links
Snippet
The design, synthesis, and biological properties of novel inhibitors of the Na+, K+-ATPase as potential positive inotropic compounds are reported. Following our model of superposition between cassaine and digitoxigenin, digitalis-like activity has been elicited …
- 150000001875 compounds 0 title abstract description 63
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0036—Nitrogen-containing hetero ring
- C07J71/0042—Nitrogen only
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Similar Documents
Publication | Publication Date | Title |
---|---|---|
De Munari et al. | Structure-based design and synthesis of novel potent Na+, K+-ATPase inhibitors derived from a 5α, 14α-androstane scaffold as positive inotropic compounds | |
Ling et al. | 17-Imidazolyl, Pyrazolyl, and Isoxazolyl Androstene Derivatives. Novel Steroidal Inhibitors of Human Cytochrome Cl7, 20-Lyase (P45017α) | |
Schönecker et al. | Conformational design for 13α-steroids | |
Hartmann et al. | Synthesis and evaluation of novel steroidal oxime inhibitors of P450 17 (17α-hydroxylase/C17− 20-lyase) and 5α-reductase types 1 and 2 | |
Wang et al. | Synthesis of B-ring homologated estradiol analogues that modulate tubulin polymerization and microtubule stability | |
Varela et al. | New structure–activity relationships of A-and D-ring modified steroidal aromatase inhibitors: design, synthesis, and biochemical evaluation | |
Cepa et al. | Structure− activity relationships of new A, D-ring modified steroids as aromatase inhibitors: design, synthesis, and biological activity evaluation | |
Allan et al. | Modification of estrone at the 6, 16, and 17 positions: novel potent inhibitors of 17β-hydroxysteroid dehydrogenase type 1 | |
Sepe et al. | Conicasterol E, a small heterodimer partner sparing farnesoid X receptor modulator endowed with a pregnane X receptor agonistic activity, from the marine sponge Theonella swinhoei | |
Deive et al. | Synthesis of cytotoxic 6 E-hydroximino-4-ene steroids: Structure/activity studies | |
Hughes et al. | 2-Methoxyestradiol and analogs as novel antiproliferative agents: analysis of three-dimensional quantitative structure-activity relationships for DNA synthesis inhibition and estrogen receptor binding | |
Kudova et al. | A new class of potent N-methyl-D-aspartate receptor inhibitors: Sulfated neuroactive steroids with lipophilic D-ring modifications | |
Yadav et al. | Synthesis of some novel androstanes as potential aromatase inhibitors | |
Roleira et al. | C-6α-vs C-7α-substituted steroidal aromatase inhibitors: Which is better? Synthesis, biochemical evaluation, docking studies, and structure–activity relationships | |
Ali et al. | Benign synthesis of thiazolo-androstenone derivatives as potent anticancer agents | |
Li et al. | Synthesis and evaluation of pregnane derivatives as inhibitors of human testicular 17α-hydroxylase/C17, 20-lyase | |
Varela et al. | Design, synthesis and biochemical studies of new 7α-allylandrostanes as aromatase inhibitors | |
Kuznetsov et al. | New estrogen receptor antagonists. 3, 20-Dihydroxy-19-norpregna-1, 3, 5 (10)-trienes: Synthesis, molecular modeling, and biological evaluation | |
Salomatina et al. | Deoxycholic acid as a molecular scaffold for tyrosyl-DNA phosphodiesterase 1 inhibition: A synthesis, structure–activity relationship and molecular modeling study | |
Wölfling et al. | Synthesis and receptor-binding examinations of the normal and 13-epi-D-homoestrones and their 3-methyl ethers | |
Al-Masoudi et al. | New biaryl-chalcone derivatives of pregnenolone via Suzuki–Miyaura cross-coupling reaction. Synthesis, CYP17 hydroxylase inhibition activity, QSAR, and molecular docking study | |
Wankhede et al. | Synthesis of novel isoxazole-linked steroidal glycoconjugates—an application of a novel steroidal nitrile oxide | |
Anderson et al. | Conformationally constrained anesthetic steroids that modulate GABAA receptors | |
Jin et al. | Copper-Catalyzed Cyclization of Steroidal Acylaminoacetylenes: Syntheses of Novel 11β-Aryl-17, 17-spiro [(4 ‘H, 5 ‘-methylene) oxazol]-Substituted Steroids | |
Gaši et al. | Synthesis and biological evaluation of some 17-picolyl and 17-picolinylidene androst-5-ene derivatives |